NEOPLASMS BY HISTOLOGIC TYPE
Clinical trials for NEOPLASMS BY HISTOLOGIC TYPE explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS BY HISTOLOGIC TYPE trials appear
Sign up with your email to follow new studies for NEOPLASMS BY HISTOLOGIC TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a vaccine keep early prostate cancer in check?
Disease control Not yet recruitingThis phase 2 trial tests a new vaccine (TriAdeno) plus an immune-boosting drug (N-803) in 52 men with early-stage prostate cancer who are currently on active surveillance. The goal is to see if the combination can increase immune cell activity inside the tumor and possibly slow o…
Matched conditions: NEOPLASMS BY HISTOLOGIC TYPE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 23, 2026 11:56 UTC
-
Could existing cancer drugs tackle rare tumors? new trial aims to find out
Disease control Not yet recruitingThis trial tests whether two approved drugs, dabrafenib and trametinib, can treat rare cancers that have a specific genetic change called BRAF V600. These drugs are already used for melanoma and lung cancer, but researchers want to see if they help people with other cancer types.…
Matched conditions: NEOPLASMS BY HISTOLOGIC TYPE
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC